Put Your Foot Down
July 16, 2012
The Justice Department’s $3 billion judgment against GlaxoSmithKline for criminal actions in their marketing of prescription drugs is a minor penalty to pay relative to the tens of billions they made in the process. Chock it up to the cost of doing business! What did GlaxoSmithKline do? The business of GlaxoSmithKline involved the promotion of drugs for unapproved patient populations and for unapproved purposes and lobbying doctors to prescribe their products by offering trips, tips and other perks in return.